This Could Be the Next Big Pot Stock
Pot stocks are a dime a dozen these days. There is no shortage of companies out there touting that their cannabis is higher quality than their peers. For investors, it makes investing in a cannabis company all the more difficult, especially when it comes to finding up-and-coming stocks.
Being able to tell which stock is a pretender and which one is the real deal isn't an easy task, but this little-known pot stock has a competitive advantage over its peers.
Amyris (NASDAQ: AMRS) is in the business of health and wellness and purports to produce pure ingredients for its customers. In March 2019, the company announced that it signed an agreement worth potentially $300 million with Lavvan, a then-recently formed company. The companies agreed to work together in bringing cannabinoid products to market, with Amyris focusing on the research and development part of the process.
Source Fool.com
